Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis.

Donato Rigante, Jurgen Sota, Antonella Insalaco, Rolando Cimaz, Maria Alessio, Marco Cattalini, Romina Gallizzi, Maria Cristina Maggio, Giuseppe Lopalco, Francesco La Torre, Claudia Fabiani, Manuela Pardeo, Alma Nunzia Olivieri, Paolo Sfriso, Carlo Salvarani, Carla Gaggiano, Salvatore Grosso, Claudia Bracaglia, Fabrizio De Benedetti, Luca Cantarini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

We have evaluated drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis. Our findings suggest an excellent overall drug retention rate for both anakinra and canakinumab that might be further augmented by paying attention to adverse events and employing these agents as first-line biologics in an early disease phase.
Lingua originaleEnglish
pagine (da-a)1-2
Numero di pagine2
RivistaPEDIATRIC RHEUMATOLOGY ONLINE JOURNAL
Volume10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
Stato di pubblicazionePubblicato - 2019

Keywords

  • Juvenile idiopathic arthritis

Fingerprint

Entra nei temi di ricerca di 'Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis.'. Insieme formano una fingerprint unica.

Cita questo